Olin Stock Slides As Earnings Miss Triggers Target Cuts

Olin Corporation faces heightened pressure as regulatory scrutiny on chemical safety deepens, and its stocks have been trading down by -15.52 percent.

Weekly Update Jul 27 – Jul 31, 2026: On Saturday, August 01, 2026 Olin Corporation stock [NYSE: OLN] is trending down by -15.52%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Materials industry expert:

Analyst sentiment – negative

Olin’s current fundamentals reflect a stressed but asset-rich chlor-alkali and epoxy platform under cyclical pressure. Revenue of ~$6.8B with gross margin only 6.4% and EBIT margin negative on a trailing basis point to poor pricing power and high fixed costs. Leverage is elevated (total debt/equity 1.9x, interest coverage 2.2x), while FCF in the latest quarter was -$21M despite $122M in D&A. ROE has swung from +24.7% to -9.9% LTM, underscoring a deteriorating return profile.

Technically, OLN has broken down sharply from the low-$22s to sub-$19 in just a few sessions, confirming a clear bearish trend on the weekly tape. The long upper wick and intraday reversal from 22.39 to a 20.97 close, followed by a gap down to 18.51, indicate aggressive supply and likely elevated volume on the breakdown. The key actionable level is resistance at $21.00–21.25; rallies into that zone are sell opportunities with stops just above $22.

Near term, the setup is negative. Q2 EPS of -$0.12 missed +$0.10 consensus, revenue declined, and FCF turned negative, validating BMO’s and Goldman’s target cuts ($25 and $24) and their warnings about weak housing/autos and constrained basic chemicals. Versus broader Materials and Chemicals indices, Olin now screens cheaper on price-to-sales (0.38x) but justifiably so given subpar margins, high leverage, and poor earnings visibility. Base-case outlook: tradeable range $17–22 with structural resistance near $22; risk-reward favors a cautious underweight.

Quick Financial Overview

Olin Corporation enters the back half of 2026 in a clear earnings downtrend. The company posted Q2 2026 revenue of about $1.74B, but still delivered a net loss of $13.3M and diluted EPS of -$0.12. That loss compares with a smaller $0.01 per-share loss a year ago and sharply undercuts the +$0.10 profit analysts expected. For traders, that is not just a miss; it is a negative swing of over $0.20 versus consensus, which tends to reset sentiment for weeks, not days.

Margins show why OLN is struggling. Gross margin sits near 6.4%, with EBITDA margin at 6.1%, but EBIT margin has slipped into negative territory around -1.5%. Profitability on a continuing basis is also negative, while return on equity over the last twelve months has turned to roughly -9.9%. Yet revenue over five years still shows slight growth, and asset turnover close to 0.9 signals the core business is active; the problem is pricing power and costs, not volume collapse.

Leverage is another key piece of the puzzle. Total debt to equity near 1.9 and a leverage ratio around 4.2 mean Olin Corporation is carrying meaningful debt, with interest coverage only about 2.2 times. Cash flow paints a mixed picture: operating cash flow in the latest quarter was positive at $7.9M, but free cash flow was roughly -$21.1M after about $29M of capital spending. A roughly 4.3% dividend yield and a $0.20 quarterly dividend per share remain in place, but traders should recognize that negative free cash flow and high leverage can make that payout a focal point if conditions worsen.

On the chart, OLN has clearly reacted to these pressures. In the latest week, price popped to an intraday high above $22 early, then slid hard after earnings. The stock dropped from the low-$22 area down toward $21 and then broke sharply, with a weekly low near $18.41 and a close at $18.73. Intraday, a 5-minute bar shows a gap down from about $20.48 and a flush to roughly $17.73 before stabilizing back to $18.51. That kind of wide-range, high-volatility session usually reflects forced repositioning as funds and active traders digest a major earnings shock.

Valuation ratios show why some traders may still be tempted to bottom-fish OLN. A price-to-sales multiple of about 0.38 and price-to-book near 1.46 are not demanding in absolute terms, especially for a company with over $6.78B in annual revenue and tangible operations across chlor-alkali and related chemicals. However, negative reported earnings make traditional price-to-earnings less useful, and the recent cut price targets from both BMO Capital and Goldman Sachs suggest the Street is not in a rush to bid the stock back up. For now, OLN looks like a value trap candidate until margins and cash flow stabilize.

Conclusion

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

• Penny Stocks Trading Guide
• Best Penny Stocks Under $1 to Buy Today
• Top 8 Penny Stocks to Watch on Robinhood

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

• AI Penny Stocks
• Robinhood Penny Stocks
• Top Biotech Stocks